porfiromycin has been researched along with Osteogenic Sarcoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| al-Sarraf, M; Izbicki, R; Reed, ML; Vaitkevicius, VK; Vaughn, CB | 1 |
1 trial(s) available for porfiromycin and Osteogenic Sarcoma
| Article | Year |
|---|---|
Further clinical trials with porfiromycin (NSC-56410) (large intermittent doses).
Topics: Adenocarcinoma; Adult; Anemia; Astrocytoma; Blood Cell Count; Blood Platelets; Carcinoma; Carcinoma, Squamous Cell; Child; Clinical Trials as Topic; Cystadenoma; Female; Humans; Leukocyte Count; Neoplasms; Osteosarcoma; Porfiromycin; Rhabdomyosarcoma | 1972 |